Amaal Aldakheel

Dr. Amaal Aldakheel


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
AAAli Abusrair
Ali Abusrair
SBS. Bohlega
S. Bohlega
AAA. Al-Semari
A. Al-Semari
FAF.S. Al-Ajlan
F.S. Al-Ajlan
KAK. Al-Ahmadi
K. Al-Ahmadi
AAAmaal Aldakheel
Amaal Aldakheel
BACKGROUND AND PURPOSE: Woodhouse-Sakati syndrome is a rare autosomal recessive disorder characterized by hypogonadism, alopecia, diabetes mellitus, and progressive extrapyramidal signs. The disease is caused by biallelic pathogenic variants in the DCAF17 gene. The purpose of this study was to describe the spectrum of brain MR imaging abnormalities in Woodhouse-Sakati syndrome. MATERIALS AND METHODS: We reviewed brain MR images of 26 patients with a clinical and genetic diagnosis of Woodhouse-Sakati syndrome (12 males, 14 females; age range, 16–45 years; mean age, 26.6 years). Follow-up studies were conducted for 6 patients. RESULTS: All patients had abnormal MR imaging findings. The most common abnormalities were a small pituitary gland (76.9%), pronounced basal ganglia iron deposition (73%), and white matter lesions in 69.2%. White matter lesions showed frontoparietal and periventricular predominance. All white matter lesions spared subcortical U-fibers and were nonenhanced. Prominent perivascular spaces (15.3%) and restricted diffusion in the splenium of the corpus callosum (7.6%) were less frequent findings. Follow-up studies showed expansion of white matter lesions with iron deposition further involving the red nucleus and substantia nigra. Older age was associated with a more severe degree of white matter lesions (P < .001). CONCLUSIONS: Small pituitary gland, accentuated iron deposition in the globus pallidus, and nonenhancing frontoparietal/periventricular white matter lesions were the most noted abnormalities seen in our cohort. The pattern and extent of these findings were observed to correlate with older age, reflecting a possible progressive myelin destruction and/or axonal loss. The presence of pituitary hypoplasia and white matter lesions can further distinguish Woodhouse-Sakati syndrome from other neurodegenerative diseases with brain iron accumulation subtypes.

13 February 2023 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
SBSaeed Bohlega
Saeed Bohlega
AAAli Abusrair
Ali Abusrair
ZAZainah Al-Qahtani
Zainah Al-Qahtani
FGFrancisco J. Guzmán-Vega
Francisco J. Guzmán-Vega
RRReshmi Ramakrishnan
Reshmi Ramakrishnan
SAStefan Arold
Stefan Arold

3 October 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
NQNajeeb Qadi
Najeeb Qadi
YAYara Alkhodair
Yara Alkhodair
WAWaad Alshammari
Waad Alshammari
AAAmaal Aldakheel
Amaal Aldakheel
Background: Dementia is a global health challenge projected to nearly triple by 2050, especially in the Middle East and North Africa (MENA). Understanding its epidemiology and economic impact is vital for public health planning. Objective: This systematic review aims to synthesize evidence on dementia, particularly the prevalence of Alzheimer's disease, its economic burden, and caregiving in MENA countries, to facilitate informed policy-making and effective resource allocation. Methods: We performed a random-effects meta-analysis to determine the pooled prevalence of dementia from studies published between 2014 and 2025 in PubMed, Scopus, and Google Scholar. Two reviewers independently selected and extracted data, assessing bias risk with the Cochrane Risk of Bias Tool. This review followed PRISMA 2020 guidelines and is registered in PROSPERO (CRD42024550935). Results: Twelve studies met the criteria, showing dementia prevalence in MENA countries from 1.1% to 7.9%, with higher rates in Iran, Israel, and Lebanon, highlighting the need for public health campaigns. The annual estimated cost for those aged 50 and older is about USD 8.18 billion. Caregiving mainly fell to female family members, with larger socioeconomic impacts than in other regions. Conclusions: Dementia is a growing public health concern in MENA, requiring improved healthcare infrastructure, increased caregiver support, and targeted research to fill knowledge gaps.

10 April 2018 in Neurology
Verified
Journal Article
Closed access
AAAli Abusrair
Ali Abusrair
SBSaeed Bohlega
Saeed Bohlega
FAFahad Al-Ajlan
Fahad Al-Ajlan
AAAbdulaziz Al-Semari
Abdulaziz Al-Semari
BMBader Mohamed
Bader Mohamed
AAAmaal Aldakheel
Amaal Aldakheel

20 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
AAAmaal Aldakheel
Amaal Aldakheel
NQNajeeb Qadi
Najeeb Qadi
Background/Objectives: Cognitive impairment affects most people with Parkinson’s disease (PD); mild cognitive impairment is present in 25–40% of people with PD without dementia, and nutritional advice often exceeds the evidence. We reviewed the human evidence that dietary patterns or nutritional supplements improve cognition in established PD, separating objective cognitive outcomes from patient-rated and biomarker outcomes. Methods: Critical narrative review reported according to SANRA. Sources were PubMed, Embase, Web of Science and Cochrane CENTRAL (inception to 29 September 2026) and reference lists. Controlled intervention studies in established idiopathic PD with an objective cognitive outcome or a specifically rated cognitive symptom formed the evidence set, appraised on risk-of-bias domains and classified by an explicit rule. Results: Twenty-three randomized controlled studies met the criteria (five dietary patterns, 18 supplements). Favorable between-group differences were reported in six studies (Mediterranean diet, a ketogenic pilot, creatine–coenzyme Q10, a probiotic, saffron and ginkgo leaf extract), all with fewer than 100 participants and heterogeneous cognitive endpoint status. The three largest trials did not demonstrate cognitive benefit. Other reports showed nonsignificant comparisons or did not provide a between-group cognitive estimate; one used only a rated symptom. No study showed durable functional benefit or reduced progression to dementia. Conclusions: No nutritional intervention has independently replicated, durable cognitive efficacy in PD. Nutritional adequacy, correction of documented deficiency, dysphagia care and individualized levodopa–meal timing remain the clinical priorities; a Mediterranean-style pattern is a reasonable default, not a cognitive treatment.

5 August 2026 in Life
Verified
Journal Article
Open access
PDF file
NQNajeeb Qadi
Najeeb Qadi
AAAmaal Aldakheel
Amaal Aldakheel
ESEslam Mahmoud shosha
Eslam Mahmoud shosha
Dementia is a growing global health challenge, yet many determinants of late-life cognitive decline emerge decades before symptoms appear. Midlife is a practical window for prevention because hypertension, diabetes, obesity, dyslipidemia, smoking, physical inactivity, unhealthy diet, sleep disturbance, and social isolation can be identified and modified before substantial brain injury becomes apparent. This narrative review synthesizes evidence linking midlife vascular and lifestyle exposures to late-life cognitive impairment and dementia. The most consistent data support a life-course model in which cumulative vascular, metabolic, inflammatory, and behavioral risks interact with neurodegenerative pathology and cognitive reserve. Vascular and metabolic factors act largely through small-vessel disease, endothelial dysfunction, and inflammation, whereas physical activity, healthy diet, sleep, and social engagement may strengthen resilience. Although observational evidence is vulnerable to confounding and single-risk trials may underestimate cumulative benefit, multidomain prevention remains biologically plausible and clinically actionable, as recent trials reaffirm. These priorities are especially salient in the rapidly transitioning Gulf Cooperation Council (GCC) countries, where midlife cardiometabolic risk is high and local evidence is limited. Dementia prevention should be embedded in routine midlife care, with vascular risk management and sustained lifestyle support treated as core elements of lifelong brain health.